Patents Assigned to GX BioSystems A/S
  • Patent number: 6017730
    Abstract: The survival of cells is limited by introducing into the cells a regulatably expressible gene whose expression results in the formation of a cytoplasmatically active hydrolytic enzyme. Populations of cells containing, in addition to such a regulatably expressible gene, a DNA coding for an immunologically active, pesticidally active or environmental pollutant-degrading gene product, may be useful in immunologically active compositions, pesticidally active compositions and environmental pollutant-degrading compositions, respectively.
    Type: Grant
    Filed: May 4, 1998
    Date of Patent: January 25, 2000
    Assignee: GX BioSystems A/S
    Inventors: Soren Molin, Michael Givskov, Claus Sternberg Kristensen, Asim K. Bej, Leo Eberl
  • Patent number: 5834233
    Abstract: The survival of cells is limited by introducing into the cells a regulatably expressible gene whose expression results in the formation of a cytoplasmatically active hydrolytic enzyme. Populations of cells containing, in addition to such a regulatably expressible gene, a DNA coding for a pesticidally active or environmental pollutant-degrading gene product, may be useful in pesticidally active compositions and environmental pollutant-degrading compositions, respectively.
    Type: Grant
    Filed: October 18, 1995
    Date of Patent: November 10, 1998
    Assignee: GX BioSystems A/S
    Inventors: Soren Molin, Michael Givskov, Claus Sternberg Kristensen, Asim K. Bej, Leo Eberl
  • Patent number: 5702916
    Abstract: A replicon, in which a nucleotide sequence encoding a cell killing function is regulatably expressed when the replicon is harbored in one type of host cell (primary host cell), so that cells harboring the replicon are killed under conditions under which the cell killing function is expressed, and the nucleotide sequence encoding the cell killing function is regulatably or constitutively expressed when the replicon is harbored in another type of host cell (secondary host cell), so that cells harboring the replicon are invariably killed or killed under conditions under which the cell killing function is expressed, may be used in a method of active biological containment of cells under defined environmental conditions. The biological containment principle may be utilized in the industrial production of a biosynthetic product by recombinant DNA techniques, when deliberately releasing a genetically engineered microorganism to the natural environment or in the preparation of a live vaccine.
    Type: Grant
    Filed: May 25, 1995
    Date of Patent: December 30, 1997
    Assignee: GX Biosystems A/S
    Inventors: S.o slashed.ren Molin, Poul Kirketerp Andersson, Kenn Axo Gerdes, Per Klemm
  • Patent number: 5670370
    Abstract: A replicon, in which a nucleotide sequence encoding a cell killing function is regulatably expressed when the replicon is harboured in one type of host cell (primary host cell), so that cells harbouring the replicon are killed under conditions under which the cell killing function is expressed, and the nucleotide sequence encoding the cell killing function is regulatably or constitutively expressed when the replicon is harboured in another type of host cell (secondary host cell), so that cells harbouring the replicon are invariably killed or killed under conditions under which the cell killing function is expressed, may be used in a method of active biological containment of cells under defined environmental conditions.The biological containment principle may be utilized in the industrial production of a biosynthetic product by recombinant DNA techniques, when deliberately releasing a genetically engineered microorganism to the natural environment or in the preparation of a live vaccine.
    Type: Grant
    Filed: May 30, 1995
    Date of Patent: September 23, 1997
    Assignee: GX BioSystems A/S
    Inventors: S.o slashed.ren Molin, Poul Kirketerp Andersson, Kenn Ax.o slashed. Gerdes, Per Klemm